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In a double-blind study with randomly assigned topi-
cal solutions of 0%, 1%, 3%, or 5 % minoxidil, the blood 
flow in balding scalps of 16 human volunteers was meas-
ured by the noninvasive techniques of both laser Doppler 
velocimetry (LDV) and photopulse plethysmography 
(PPG) . On two <:ons~c~tive days, ~n 0.25-ml volume ~f 
the assigned minoxidil formulatiOn was spread um-
formly over a 100-cm2 area of each side of the bald scalp 
and cutaneous blood flow was recorded for the following 
4 h. Both measurement techniques showed that the 5% 
minoxidil solution stimulated the microcirculation of the 
bald scalp. Increased blood flow was greater with the 
5% minoxidil solution than with .the other treatments. 
Measured by LDV on day 1, the mcrease (p < 0.0001) 
in blood flow occurred within 15 min of ap.plication of 
the 5% solution of minoxidil and was maintamed at least 
through hour 1. On day 2, LDV showed blood flow 
stimulation with the 5% solution was 3 - fold (p < 0.000 1) 
within 15 min of application and was so maintained for 
about 1 h. Measured by PPG, the only statistically sig-
nificant (p < 0 .01) response occurred with ~he day 2 
application of the 5% minoxidil solution. PPG IS depend-
ent on local blood volume and is only weakly correlated 
to cutaneous blood flow, which makes it unsuitable for 
this kind of study. Analysis of vital signs for days 1 and 
2 revealed no systemic effect from treatment with mi-
noxidil suggesting that the blood flow stimulation was 
directl; related to the topical application of minoxidil. 
Minoxidil an orally administered antihypertensive agent, 
may be usef'ul in the development of a model for studyin.g 
hypertrichosis, ma le-pattern baldness, and ~ther alopectas. MI-
noxidil is a direct-acting peripheral vasodilator that reduces 
elevated systolic and diastolic blood pr~ssure by de.creas!ng 
pe ripheral vascular resistance. Minox1dil does not mterfere 
with vasomotor reflexes and, therefore, does not produce ortho-
static hypotension . Following oral administration of minoxidil 
and in association with the reduction in peripheral vascular 
resistance, cardiac output is augmented, salt and water are 
retained, and plasma renin activity rises [1-3]. . 
Some patients using minoxidil for control o~ their hyperte n-
sion have experienced a general and unpredictable hypertri-
chosis of their facia l and body vellus hairs. Changes in patterns 
of hair growth in these patients have been observed in the area 
between the eyebrows and existing hairline, in the malar and 
temporal areas, between the eyebrows, and on the ?ack, .a rms, 
shoulders, and legs. The incidence of the hypertnchos1s has 
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been between 30-50% for males and 50- 80% for females. Hair 
regrowt h in a patient with male-pattern baldness was described 
in 2 case reports of hypertensive patients treated with oral 
rninoxidi l [4,5 ]. New and increased hai r growth as a s ide effect 
was also reported in the ea rly clinical studies involving 5 of 8 
patients t reated wit h oral minoxidil for hypertension for 2 
months [6]. 
It has been hypothesized that the mechanism by which oral 
minoxidil stimulates hair growth is its potent vasodilation and 
that it is this stimulation of the microcirculation surrounding 
the hair follicle that leads to hypertrichosis. If this is true, then 
a minox idil topical preparation applied to the scalp could lead 
to direct stimulation of the microcirculation surrounding the 
hair follicle and perhaps a reversal of t he process of alopecia. 
In the present study , we used two noninvasive techniques to 
measure cutaneous blood !1ow. They were laser Doppler velo-
cimetry, a qualitative method, and photopulse plethysmogra-
phy, a semiqualitative met hod. The cutaneous scalp blood fl ow 
was measured in bald but otherwise healthy volunteers follow -
ing topical application of 0% (vehicle only), 1%, 3%, or 5% 
minoxidil solutions to balding areas of t he scalp. 
METHODS 
In this double-b lind study, 16 healthy, balding, male volunteers , aged 
24- 76, were ra ndomly assigned to rece ive I of 4 concentra tions o f 
minoxidil app lied topica lly t.o the scalp 1 time on 2 successive days. 
The 4 treatments used were 0%, I %, 3%, a nd 5% concentrations of 
minoxidil in a vehicle of varying proportions of propylene glyco l (10-
50 %), ethanol (30- 70%), a nd water (21 %). The 0 % (placebo) treatment 
was the vehicle with 50% alcohol. At. the time of se lection, a complete 
physical examination was done and the subject's m edical history a nd 
vita l s igns (pu lse, respira t ion, body weight. a nd blood pressure) were 
recorded. Volunteers we re not to use any form of medication for 14 
days prior to the study and were not. to receive medication other th an 
the test drug during the study. Informed consent was obtained from a ll 
volunteers. 
In all treatme nt groups, cuta neous blood t1ow was measured by the 
following two noninvasive tec hniques. Laser Doppler uclucim.etry (LDV) 
[7- 9] operates on the Doppler principle. Light from a 5- mW He-Ne 
lase r is transmitted to the skin through a quartz optica l fiber. The light 
is backsca tt.e red from stationary skin components and by red blood 
cells moving in the derma l cap illa ri es, which are encountered as the 
radiat ion penetrates t.o a depth of 1- 1..5 mm (approximate ly 0.05 
inches). The instrument separa tes out the frequ ency (i.e., Dopple r)-
shift.ed component. and converts it. to a s ingle " t1ow pa ramete r" which 
is registered as a vo ltage output. This output cor relates semiquan t.it.a-
tively with pe ripheral cuta neous blood flow rates. Phot.opulse plethys-
mography (PPG) [ 10,11] uses a diode that. emits infrared light and 
determines cha nges in blood volume passing through the microcircu-
lation by the percentage of incident radiation absorbed. The PPG emits 
infrared rad iation, the frequency of which covers wavelengths strongly 
abso rbed by hemoglobin. It follows that cha nges in blood volume in 
t he region of s kin under the probe cause the PPG output to cha nge as 
t he percentage of incident radiation absorbed is altered. 
On study days 1 a nd 2, blood pressure and pulse rates were obta ined 
before the drug was app lied. Baseline measurement of blood flow in 
the scalp skin at the intended s ite of drug application was made with 
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both techniques, LDV on one half of' the scalp and PPG on the other 
ha lf. 
On day 1, t he tota l 0.25 ml contents of' the pipette containing the 
random ly ass igned medicat ion was distributed uniformly over 100 cm2 
on eac h side of' the bald scalp area. The solmion was released s lowly 
from t he pipeUe w avoid run -off' and the need to rub it into the bald 
sca lp with the fingers. A 15-min drying period was a llowed after drug 
app lication before the recording began. The LDV and PPG probes were 
then posit ioned on the scalp at t he site of' drug app lication . Cutaneous 
blood flow was recorded continuously for 40- 60 min, and t hen inter-
mittently for 4 h. Blood pressure and pulse rates were taken after t he 
4-h recording. Volunteers were asked to not wash t heir scalp prior to 
day 2. 
On day 2, vita l s igns and a baseline blood flow measurement were 
again obtained. This measurement served as both the 24-h measure-
ment for day I and the predrug measurement for day 2. The same 
randomly assigned formulation as on day 1 was applied to the same 
sca lp site, and cutaneous blood flow was reco rded as on day l. Vital 
signs were aga in obtained afte r the 4-h sess ion. 
The blood flow data changes from baseline values within treatment 
groups were analyzed using the paired t-test. Differences between 
trea tment. groups were evaluated using ana lys is of variance. A summary 
result was obtained by averagin g t he scores, excluding the pretreatment 
sco res, across the test periods. Vital signs were ana lyzed using the 
paired t-t.est. within t reatment groups and analysis of variance across 
treatment groups. 
RESULTS 
Fig 1 shows mean blood flow values for day 1 applicat ions of 
0%, 1%, 3%, and 5% solutions of minoxidil obtained by the 
LDV technique. The 1%, 3%, and 5% solutions produced in-
creases in blood flow that suggested a dose response. The 0% 
solution showed a slight increase in blood flow through the first 
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40 min of recording. This is the time period of continuous 
recording, suggesting t hat the presence of the probe or t h e 
vehicle itself (50% alcohol) had some small vasodilatory effect. 
When the data were summari zed over t ime periods, t he 5% 
solut ion showed a statistically sign ificant ( p < 0.0001) increase 
in blood flow when compared with the other treatments. 
Fig 2 shows t he mean blood fl ow values for day 2 as obtained 
by LDV. The 24- h measurements did not differ from those of 
day 1 nor from the time curves fo r the 0%, 1%, or 3% so lut ions. 
The 5% solution, however, caused a 3-fold increase in blood 
flow; t his increase was maintained for t he first hour followina 
drug application. After 1 h, blood flow was the same for all 
formulations. When the data were summarized over time pe-
riods, t he 5% solution showed a statistically s ignificant ( p < 
0.0001) difference in blood flow. 
Fig 3 shows mean blood !1ow measurements for day 1 as 
obtained with the PPG technique. There were no statistically 
significant differences among t he 4 treatment groups ( p > 
0.05). 
Fig 4 shows mean blood flow measurements for day 2 as 
obtained by PPG. When the data were summarized over time 
periods, the 5% solution bad increased blood flow (p < 0.0016) 
when compared with the other treatments; this increase was 
maintained t hrough hour 2. 
The monitoring of pulse rate and blood pressure afte r topical 
app lications of minoxidil gave no ev idence of a systemic effect. 
DISCUSSION 
The most significant point of t his study is that the pharma-
codynamics of topical minoxidil can now be studied in t he bald 
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scalp, right at the s ite of action. These pharmacodynamic data 
will be most relevant to the design and interpretation of clinica l 
efficacy studies. For example, the data show t he time course of 
activ ity after topically applied minoxidil to be of shorter dura-
t ion t han would be expected of a topical preparation. Percuta-
neous absorption is usually a slow process, but t he peak of 
activity after application of minoxidil cont inued fo r only l h. 
T his suggests t hat mult iple daily app lications of minoxidil may 
improve t he response and subsequent efficacy. Further, in t his 
study t he response on day 2 was greater t han on day 1. This 
s uga-ests an increase in t he rate or amount of absorption, or 
both or perhaps some residual activity of minoxidi l from t he 
day '1 application. Human skin exhibits a reservoi r effect 
whereby some chemicals can be retained following topical ap-
plication, a l tho~gh the reser~oir chemical is normally lost ~ur­
ing sk in exfoli.at1on. Co~1com 1tant treatments such as occlus10n, 
however can mlub1t th1s process of loss and allow the reservOir 
c hemicai to be substantially absorbed. Pharmacodynamic stud-
ies following chronic application of minoxidil could indicate 
when or indeed if, steady state conditions are established. 
Wl~ile positive pharmacodynamic resul ts such as those in 
th is study are excit ing, their clinical relevance to hair growth 
needs to be evaluated through controlled efficacy studies. The 
effect of vasodilation on hair growth has not been shown, nor 
h ave correlations of pharmacodynamics and percutaneous ab-
sorption been established. It is unusual t~ find percutaneous 
absorptio n completed m 1 h, the tune of ph~rmacodynam1c 
response in t his stud~. Perhaps tl~e s.calp reqUires a t hreshold 
concent ration to mamtam vasodilatiOn, as suggested by the 
dose response in this study. The vasodilator effect of the vehicle 
(50% alcohol} seen in t he present study sugg~sts that future 
studies should include vehicles without alcoholm order to more 
precise ly evaluate the effect of t he pharmacologic substrate 
under study. 
The two noninvasive techniques used to measure blood fl ow 
in th is study, LDV a nd PPG, are qualitative and semiquali ta-
tive respectively. PPG is dependent on t he local blood volume 
and,is only weakly correlated to t he cutaneous blood flow rate; 
it is t hus unsu itable for studies of cutaneous blood flow. LDV 
has the same problem to some degree, since it is dependent on 
the local vascular content of erythrocytes and also on t he 
eryth rocyte velocity. LDV is, nevertheless, able to give mo~e 
semiquantitative results of cutaneous blood flow rates and IS 
su itable for t he present purpose. 
A primary assu mpt!on in t he presen.t study is t hat bloo~ flow. 
of t he upper layers of the cutaneous t1ssue IS representat ive of 
that of the germinal part of the hair follicle located subcuta-
neously 4- 6 mm from the surface. It would be desirable and is 
possib le, however, to obtain both t he cutaneous and the sub-
cutaneous blood flow rates by performing supplementary stud-
ies with t he ':"'Xe washout method [12]. The use of this simple, 
reliable method 30 min before and 30 min after topical appli-
cations of minoxidil could confirm our observations in this 
study and wou ld yield a calibration of t he results obtained by 
t he LDV technique. We, therefore, recommend that future 
studies of cutaneous blood f1ow with topical minoxidil include 
the use of the ""~Xe washout method [7,12 ,13 ]. 
The authors wish to thank Dorothy J. Marshall of The Upjohn 
Compa ny for he r valuable edito ria l ass istance. 
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